One-Year Evaluation of Paliperidone Palmitate 6-Monthly: Satisfaction and Perceived Effectiveness Among Patients, Relatives, and Clinicians

One-Year Evaluation of Paliperidone Palmitate 6-Monthly: Satisfaction and Perceived Effectiveness Among Patients, Relatives, and Clinicians

Sofía Manchado Perero,1 Ana Rodríguez Lorente,2 Alba García-Pérez,3 Guillermo Isidro García,4,5 Luis Alberto Forcen-Muñoz,6 Santiago Ovejero,1 Rocío Sáez Povedano,7 Ana Luisa González-Galdámez,8 Laura Mata Iturralde,1 Mariluz Ramirez Bonilla,4,5 Paloma Fuentes-Pérez,5 Claudia Ovejas-Catalán,5 Paula...

Full description

Saved in:

Bibliographic Details
Main Authors:	Manchado Perero S, Rodríguez Lorente A, García-Pérez A, Isidro García G, Forcen-Muñoz LA, Ovejero S, Sáez Povedano R, González-Galdámez AL, Iturralde LM, Bonilla MR, Fuentes-Pérez P, Ovejas-Catalán C, Suárez-Pinilla P, Fernandez Abascal Puente B, Omaña Colmenares M, Campos-Navarro MP, Baca-García E, Fernández AL, Benavente-López S, Platero AR, Navalón MB, Sánchez-Alonso S, Vázquez-Bourgon J, Pappa S, García-Carmona JA
Format:	Article
Language:	English
Published:	Dove Medical Press 2025-05-01
Series:	Patient Preference and Adherence
Subjects:	paliperidone-palmitate 6-monthly schizophrenia long-acting injectable antipsychotics patient satisfaction psychiatrists and family perspectives effectiveness
Online Access:	https://www.dovepress.com/one-year-evaluation-of-paliperidone-palmitate-6-monthly-satisfaction-a-peer-reviewed-fulltext-article-PPA
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Long-term effectiveness, adherence and safety of twice-yearly paliperidone-palmitate long acting-injectable in patients with schizophrenia in Europe: 2-year mirror-image data from the paliperdone-2 per year study (P2Y)
by: Sofía Manchado Perero, et al.
Published: (2025-03-01)

Gender-stratified 9-month comparison of paliperidone extended-release tablets and paliperidone palmitate injection in schizophrenia
by: Zheng Lan, et al.
Published: (2025-05-01)

The effectiveness of paliperidone palmitate at the stage of stabilizing treatment of schizophrenia in the outpatient department. Clinical observation
by: M. R. Bagautdinov
Published: (2020-01-01)

Efficacy and safety of paliperidone palmitate 1-month formulation (PP1M) for schizophrenia in southwestern China
by: Lian Gou, et al.
Published: (2025-04-01)

Efficacy and safety of once-monthly injection of paliperidone palmitate in hospitalized Asian patients with acute exacerbated schizophrenia: an open-label, prospective, noncomparative study
by: Li H, et al.
Published: (2015-12-01)

Clinical effectiveness of paliperidone palmitate 3‐monthly and 1‐monthly as monotherapy in patients with schizophrenia: A retrospective cohort study based on the Medicaid claims database
by: Chih‐Lin Chiang, et al.
Published: (2024-12-01)

Treatment Persistence of Paliperidone Palmitate 3‐Month in Patients With Schizophrenia: A Japan Medical Data Center Claims Database Analysis
by: Akihide Wakamatsu, et al.
Published: (2025-06-01)

Critical evaluation of paliperidone in the treatment of schizophrenia in Chinese patients: a systematic literature review
by: Zhang L, et al.
Published: (2016-01-01)

Head-to-Head Comparison of UHPLC-MS/MS and Alinity C for Plasma Analysis of Risperidone and Paliperidone
by: Francisco José Toja-Camba, et al.
Published: (2024-10-01)

A multidimensional assessment of adverse events associated with paliperidone palmitate: a real-world pharmacovigilance study using the FAERS and JADER databases
by: Siyu Lou, et al.
Published: (2025-01-01)

Patient social function and quality of life in schizophrenia: focus on paliperidone palmitate
by: E. V. Grigorieva
Published: (2018-07-01)

Long-Term Symptomatic and Functional Remission with Paliperidone Palmitate 6-Monthly Treatment in Schizophrenia: A 3-Year Post-Hoc Analysis
by: Hamilton JM, et al.
Published: (2025-06-01)

Cardiac Considerations in Treatment of Schizophrenia: A Case Report Highlighting the Use of Long-acting Injection Paliperidone Palmitate Depot in Schizophrenia Patient with Comorbid Wolff-Parkinson-White Syndrome
by: Suparna Kumar, et al.
Published: (2025-02-01)

Prediction of drug concentrations in humans for long-acting injectable suspensions by a semi-mechanical muscle compartment model: a case study of paliperidone palmitate
by: Panpan Yu, et al.
Published: (2025-07-01)

Improvement in social and cognitive functioning associated with paliperidone extended-release treatment in patients with schizophrenia: a 24-week, single arm, open-label study
by: Shi C, et al.
Published: (2016-08-01)

Population Pharmacokinetics of Risperidone and Paliperidone in Schizophrenia: A Systematic Review
by: Ana Carrascosa-Arteaga, et al.
Published: (2025-05-01)

Efficacy of paliperidone palmitate once-monthly (PP1M) in improving social functioning and reducing caregiver burden in patients with schizophrenia: a six-month follow-up study
by: Ling Dong, et al.
Published: (2025-07-01)

Successful treatment with olanzapine and aripiprazole of a schizophrenic patient who developed priapism after switching from risperidone to paliperidone
by: Saki Kawahara, et al.
Published: (2024-12-01)

Retrospective analysis of hospitalization rates in patients with schizophrenia 12 months before and 12 months after the switch on once-monthly long-acting injectable paliperidone palmitate
by: Totić-Poznanović Sanja, et al.
Published: (2023-01-01)

Safety and efficacy of paliperidone extended-release in Chinese patients with schizophrenia: a 24-week, open-label extension of a randomized, double-blind, placebo-controlled study
by: Hongyan Z, et al.
Published: (2016-01-01)

Post Mortem Paliperidone Blood Concentrations Following Long-Acting Injectable Treatments
by: Pietro Zuccarello, et al.
Published: (2025-05-01)

A case report of exacerbation of extrapyramidal symptoms following the switch from risperidone to paliperidone during valproate therapy
by: Emi Hata, et al.
Published: (2025-01-01)

Accidental Overdose of Paliperidone Palmitate
by: Chiedozie Ojimba, et al.
Published: (2019-01-01)

Dynamics of Clinical Manifestations and Social Functioning in Schizophrenia: A Non-interventional Observational Study of Paliperidone Palmitat Dosage Forms
by: Aleksandr M. Reznik, et al.
Published: (2024-12-01)

Development of a green GC-FID method for residual solvent analysis in paliperidone nanocrystal formulations: Validation and greenness assessment
by: Manohar S K, et al.
Published: (2025-12-01)

Characteristics and determinants of professional burnout among early career psychiatrists in Russia — results of a cross-sectional study
by: E M Chumakov, et al.
Published: (2022-04-01)

Effects of Paliperidone Palmitate on Coagulation: An Experimental Study
by: Enver Demirel Yılmaz, et al.
Published: (2014-01-01)

The History of Psychiatry in Latvia
by: Kuzņecovs, Vladimirs
Published: (1994-01-01)

Psychotherapy approaches of Iranian psychiatrists and psychologists
by: Masoumeh Mousavi, et al.
Published: (2018-04-01)

Manic Symptoms during a Switch from Paliperidone ER to Paliperidone Palmitate in a Patient with Schizophrenia
by: Kadir Demirci, et al.
Published: (2015-01-01)

A minority among Chinese psychiatrists: the current state of development of child and adolescent psychiatrists
by: Zhiwei Liu, et al.
Published: (2025-07-01)

Reform of community psychiatry in Poland
by: Bożena Zdebko
Published: (2023-04-01)

Categorizing Priorities in Mental Illness Treatments
by: Orestis Giotakos
Published: (2025-05-01)

What do patients think about psychiatrist’s attire? A Croatian study
by: Maja Škarić, et al.
Published: (2024-01-01)

Effective Oral Presentations: The Steps to Making an Impact on the Podium
by: Raviteja Innamuri, et al.
Published: (2022-08-01)

Projecting the Potential Budget Impact Analysis of Paliperidone Palmitate in Egyptian Adult Patients with Schizophrenia
by: Gihan Elsisi, et al.
Published: (2023-08-01)

Paliperidone Palmitate Associated with Necrotizing Deep Tissue Infection and Sepsis Requiring Surgical Intervention
by: Jonathan G. Leung, et al.
Published: (2015-01-01)

Indian Psychiatrists Honored with Padma Awards by the Government of India: A Biographical Sketch
by: Narayana Manjunatha, et al.
Published: (2025-07-01)

Prevalence of Organizational Cynicism Among Early Career Psychiatrists in Lithuania: An Exploratory Study
by: Ambrasas Laurynas, et al.
Published: (2023-12-01)

Attitudes toward lithium prescription among psychiatrists in Saudi Arabia: a cross-sectional study
by: Mohammad A. Alolayan, et al.
Published: (2025-06-01)